Drug intelligence / Profile preview

iodine-127

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Iodine-127 is the only stable isotope of iodine and is essential for human health, primarily as a component of thyroid hormones (thyroxine, T4, and triiodothyronine, T3), which regulate metabolism[6]. It is naturally present in some foods, added to table salt (as iodized salt), and available as a dietary supplement[9]. In medicine, iodine-127 (as various iodide salts, such as potassium iodide) is used to prevent and treat iodine deficiency disorders, including goiter and hypothyroidism, and to protect the thyroid from radioactive iodine (such as iodine-131) during nuclear emergencies by saturating the gland and reducing uptake of radioactive isotopes[1][4][8]. In diagnostic imaging, iodine-127 is not directly used due to its lack of radioactivity, but iodine-123 and iodine-131 are the main radionuclides for imaging and therapy[3][5]. Iodine-127 is also employed as an antiseptic and disinfectant, with broad-spectrum activity against bacteria, viruses, and fungi, and is used as a radiocontrast agent in X-ray imaging due to its high X-ray absorption[1][3][4].

Other names
stable iodineiodine-127iodine127iodine 127elemental iodineI-127I127I 127
02

Targets

TPO (Thyroid peroxidase)

Beyond the preview

Go deeper on iodine-127.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on iodine-127.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call